Published Date: 02 Mar 2023
DELHI: The Indian Institute of Medical Sciences (AIMS Delhi) has announced that the Professional Examination for Higher Education will be held next month.
Read Full NewsA phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.
Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.
Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.
A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.
Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.
Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.
Research is limited, but what has been done shows a possible connection.
1.
Colon cancer and exercise: Can physical activity reprogram genes?
2.
Distribution of fat could influence cancer risk, study suggests
3.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
4.
EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk
5.
Women who miss their first mammogram face higher risk of breast cancer death, study finds
1.
Myeloproliferative Disorders: Causes, Symptoms and Treatment Options
2.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
3.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
4.
Exploring the Latest Advances in PTLD Cancer Treatment
5.
The Importance of Balanced Potassium Levels in Maintaining Good Health
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
4.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation